Skip to main content
. 2019 Jul 3;11(2):117–123. doi: 10.1136/flgastro-2019-101197

Figure 2.

Figure 2

Association of trough vedolizumab levels with (A) clinical remission (Harvey-Bradshaw Index<5/partial Mayo score <2); (B) biologic remission (C-reactive protein <5 mg/L plus faecal calprotectin <250 µg/g); (C) endoscopic remission (Mayo score 0/absence of inflammation and ulceration) and (D) deep remission (clinical remission plus endoscopic remission). Violin plots show median (solid line), IQR (dotted line), maximum and minimum.